Journal article
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
eNeuro, Vol.11(2), pp.1-6
02/2024
DOI: 10.1523/ENEURO.0170-23.2023
PMCID: PMC10866330
PMID: 38351057
Abstract
Alpha-synuclein has been implicated in neurodegenerative diseases such as Parkinson's disease and dementia with Lewy bodies, with A53T and A30P mutations shown to be disease causing. It has been reported that hemizygous transgenic mice with tyrosine hydroxylase promotor-driven expression of A53T/A30P mutant alpha-synuclein in dopamine neurons provide a useful preclinical model of these conditions by virtue of developing behavioral deficits. Here, we report a lack of replication of this finding. Despite detecting robust overexpression of A53T/A30P mutant alpha-synuclein in dopamine neurons, we did not observe decreased tyrosine hydroxylase immunofluorescence or behavioral deficits in these mice. Our results demonstrate that preclinical models of synucleinopathy need careful validation in the field.
Details
- Title: Subtitle
- Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
- Creators
- Cameron Keomanivong - University of IowaJosephine Schamp - York UniversityErvina Tabakovic - University of IowaRamasamy Thangavel - University of IowaGeorgina Aldridge - University of IowaAndrew A Pieper - University Hospitals Cleveland Medical CenterNandakumar S Narayanan - University of Iowa
- Resource Type
- Journal article
- Publication Details
- eNeuro, Vol.11(2), pp.1-6
- DOI
- 10.1523/ENEURO.0170-23.2023
- PMID
- 38351057
- PMCID
- PMC10866330
- NLM abbreviation
- eNeuro
- eISSN
- 2373-2822
- Grant note
- name: Titan Neurological Fund
- Language
- English
- Date published
- 02/2024
- Academic Unit
- Neurology; Psychiatry; Iowa Neuroscience Institute
- Record Identifier
- 9984559929402771
Metrics
78 Record Views